IBOV 173,714.08 ▼ 0.06% IPSA 10,886.14 ▼ 0.56% IPC MEX 66,634.23 ▲ 0.42% MERVAL 3,199,934 ▲ 0.46% COLCAP 2,298.34 ▲ 0.58% BVL PERÚ 57,220.16 — — USD/BRL5.11▲ 0.19% USD/MXN17.53▲ 0.59% USD/CLP931.20▲ 0.67% USD/COP3,251▲ 0.61% USD/PEN3.39▲ 0.21% USD/ARS1,478▲ 0.17% USD/UYU40.23▲ 1.74% USD/PYG6,032▲ 1.81% USD/BOB10.65▲ 4.37% USD/DOP58.24▲ 1.37% USD/CRC446.12▲ 1.44% USD/GTQ7.62▲ 2.73% USD/HNL26.73▲ 1.94% USD/NIO36.62▲ 0.34% USD/VES730.65▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.59▲ 0.87% USD/TTD6.74▲ 1.70% EUR/BRL5.84▲ 0.16% BRENT 88.10 ▲ 4.59% WTI 81.78 ▲ 3.58% IRON ORE 161.91 — — COPPER 6.27 ▼ 0.40% GOLD 4,023 ▲ 0.94% SILVER 56.22 ▲ 0.58% SOY 1,203 ▲ 0.67% CORN 467.50 ▲ 5.89% WHEAT 682.75 ▲ 1.19% COFFEE 321.10 ▼ 0.06% SUGAR 14.82 ▲ 2.63% ORANGE JUICE 139.35 ▲ 4.15% COTTON 78.93 ▲ 1.60% COCOA 5,610 ▲ 7.55% BEEF 220.70 ▼ 2.81% CATTLE 339.35 ▼ 2.09% LITHIUM 68.38 ▼ 0.70% PETR4 40.90 ▲ 2.53% VALE3 72.94 ▼ 0.05% ITUB4 41.96 ▼ 1.39% BBDC4 18.29 ▼ 0.65% ABEV3 15.63 ▲ 0.19% BBAS3 20.49 ▼ 1.30% B3SA3 15.20 ▼ 1.23% WEGE3 43.63 ▲ 0.32% PRIO3 57.85 ▲ 1.87% SUZB3 41.93 ▲ 0.55% RENT3 38.23 ▼ 1.62% AZZA3 18.59 ▲ 0.32% CSAN3 3.84 ▼ 1.03% RAIZ4 0.29 — 0.00% PCAR3 2.60 ▲ 0.39% GMAT3 3.88 ▼ 1.02% PSSA3 55.14 ▼ 0.14% CVCB3 1.22 ▼ 9.63% POSI3 3.80 ▼ 2.06% SLCE3 13.53 ▼ 0.59% NATU3 8.55 ▼ 0.12% BRKM5 6.19 ▲ 1.48% RANI3 7.95 ▼ 1.61% CSNA3 5.05 ▼ 0.98% CMIN3 5.33 ▼ 2.20% USIM5 8.23 ▲ 4.18% GGBR4 24.04 ▲ 0.54% ENEV3 25.68 ▼ 1.04% CPFE3 46.87 ▼ 0.68% CMIG4 11.12 ▲ 0.27% EQTL3 39.50 ▼ 0.88% LREN3 13.42 ▼ 1.69% VIVT3 35.52 ▲ 0.14% RAIL3 13.70 ▼ 1.65% KLABIN 17.58 ▲ 1.27% RAIA DROGASIL 18.55 ▲ 0.16% RDOR3 35.78 ▼ 0.25% HAPV3 11.38 ▲ 3.93% FLRY3 16.59 ▲ 1.04% SMTO3 15.45 ▼ 1.72% UGPA3 32.07 ▲ 0.25% VBBR3 34.92 ▲ 1.60% BBSE3 41.12 ▼ 0.15% BPAC11 56.18 ▼ 0.72% CURY3 30.67 ▼ 1.98% AERI3 2.02 — 0.00% VIVARA 22.44 ▼ 3.90% COMPASS 24.88 ▼ 0.12% VAMOS 3.17 ▲ 0.32% SANB11 26.65 ▼ 0.67% ASAI3 8.50 ▼ 0.70% SBSP3 29.22 ▼ 0.27% WALMEX 49.52 ▼ 0.08% GMEXICO 200.05 ▲ 0.41% FEMSA 225.68 ▲ 0.28% CEMEX 22.69 ▼ 0.40% GFNORTE 181.34 ▲ 0.53% BIMBO 58.00 ▲ 0.14% TELEVISA 9.57 ▲ 0.53% AMX 23.00 ▲ 0.97% GAP 386.00 ▼ 1.47% ASUR 279.71 ▼ 0.44% OMA 230.06 ▼ 1.30% KOF 181.10 ▲ 1.20% GRUMA 287.32 ▲ 0.34% KIMBER 38.67 ▼ 0.28% SQM-B 65,450 ▼ 0.91% COPEC 6,250 ▲ 2.02% BSANTANDER 77.00 ▼ 1.48% FALABELLA 5,835 ▼ 0.31% ENELAM 84.04 ▼ 0.90% CENCOSUD 1,995 ▼ 0.50% CMPC 1,070 ▼ 0.37% BANCO CHILE 188.50 ▼ 0.20% LATAM AIR 24.76 ▼ 2.52% YPF 77,900 ▲ 2.40% GGAL 7,860 ▼ 0.06% PAMPA 5,170 ▲ 1.17% TXAR 665.00 ▲ 0.45% ALUAR 949.50 ▲ 1.01% TGS 9,370 ▼ 0.16% CEPU 2,264 ▲ 0.18% MIRGOR 16,875 ▲ 0.75% COME 43.84 ▼ 1.39% LOMA NEGRA 3,535 ▼ 0.63% BYMA 299.00 ▼ 0.83% TELECOM ARG 4,150 ▼ 0.72% ECOPETROL 16.09 ▲ 1.84% BANCOLOMBIA 80.41 ▲ 1.18% GRUPO AVAL 4.92 ▼ 1.01% CREDICORP 390.70 ▲ 0.84% SOUTHERN COPPER 172.48 ▼ 1.81% BUENAVENTURA 30.24 ▲ 0.23% MERCADOLIBRE 1,814 ▼ 2.34% NUBANK 13.59 ▼ 1.45% XP 16.67 ▼ 0.06% PAGSEGURO 9.04 ▼ 1.20% STONE 11.15 ▼ 0.45% GLOBANT 32.23 ▲ 0.09% TECNOGLASS 46.48 ▼ 0.75% GAP AIRPORT 220.91 ▼ 1.94% ASUR 279.71 ▼ 0.44% OMA AIRPORT 105.31 ▼ 1.77% AMX ADR 26.27 ▲ 0.50% FEMSA ADR 129.02 ▼ 0.36% CEMEX ADR 12.98 ▼ 0.92% PETROBRAS ADR 17.97 ▲ 2.86% VALE ADR 14.19 ▼ 0.21% ITAU ADR 8.21 ▼ 1.14% SANTANDER BR 5.24 ▼ 1.04% AMBEV ADR 3.03 ▼ 0.66% CSN 0.99 ▼ 0.89% GERDAU 4.73 ▲ 0.11% LATAM ADR 52.56 ▼ 1.17% BTC 63,911 ▲ 0.02% ETH 1,842 ▲ 0.05% SOL 75.07 ▲ 0.08% XRP 1.09 ▼ 0.02% BNB 566.64 ▼ 0.20% ADA 0.17 ▼ 0.09% DOGE 0.07 — 0.00% AVAX 6.62 ▲ 0.61% LINK 8.25 ▼ 0.04% DOT 0.85 ▲ 0.01% LTC 45.46 ▲ 0.70% BCH 218.81 ▼ 0.42% TRX 0.32 ▼ 0.17% XLM 0.18 ▼ 0.67% HBAR 0.07 ▲ 0.47% NEAR 1.92 ▼ 0.23% ATOM 1.50 ▼ 0.69% AAVE 88.48 ▼ 1.64% SELIC 14.25% EMBRAER 81.75 ▼ 0.02% EMBRAER ADR 64.09 ▼ 0.44% JBS 11.91 ▼ 1.00% JBS BDR 60.20 ▼ 2.11% MBRF3 15.03 ▼ 1.70% MBRFY 2.90 ▼ 1.02% INTER 5.37 ▼ 3.07% IBOV 173,714.08 ▼ 0.06% IPSA 10,886.14 ▼ 0.56% IPC MEX 66,634.23 ▲ 0.42% MERVAL 3,199,934 ▲ 0.46% COLCAP 2,298.34 ▲ 0.58% BVL PERÚ 57,220.16 — — USD/BRL 5.11 ▲ 0.19% USD/MXN 17.53 ▲ 0.59% USD/CLP 931.20 ▲ 0.67% USD/COP 3,251 ▲ 0.61% USD/PEN 3.39 ▲ 0.21% USD/ARS 1,478 ▲ 0.17% USD/UYU 40.23 ▲ 1.74% USD/PYG 6,032 ▲ 1.81% USD/BOB 10.65 ▲ 4.37% USD/DOP 58.24 ▲ 1.37% USD/CRC 446.12 ▲ 1.44% USD/GTQ 7.62 ▲ 2.73% USD/HNL 26.73 ▲ 1.94% USD/NIO 36.62 ▲ 0.34% USD/VES 730.65 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.59 ▲ 0.36% USD/TTD 6.74 ▲ 1.17% EUR/BRL 5.84 ▲ 0.16% BRENT 88.10 ▲ 4.59% WTI 81.78 ▲ 3.58% IRON ORE 161.91 — — COPPER 6.27 ▼ 0.40% GOLD 4,023 ▲ 0.94% SILVER 56.22 ▲ 0.58% SOY 1,203 ▲ 0.67% CORN 467.50 ▲ 5.89% WHEAT 682.75 ▲ 1.19% COFFEE 321.10 ▼ 0.06% SUGAR 14.82 ▲ 2.63% ORANGE JUICE 139.35 ▲ 4.15% COTTON 78.93 ▲ 1.60% COCOA 5,610 ▲ 7.55% BEEF 220.70 ▼ 2.81% CATTLE 339.35 ▼ 2.09% LITHIUM 68.38 ▼ 0.70% PETR4 40.90 ▲ 2.53% VALE3 72.94 ▼ 0.05% ITUB4 41.96 ▼ 1.39% BBDC4 18.29 ▼ 0.65% ABEV3 15.63 ▲ 0.19% BBAS3 20.49 ▼ 1.30% B3SA3 15.20 ▼ 1.23% WEGE3 43.63 ▲ 0.32% PRIO3 57.85 ▲ 1.87% SUZB3 41.93 ▲ 0.55% RENT3 38.23 ▼ 1.62% AZZA3 18.59 ▲ 0.32% CSAN3 3.84 ▼ 1.03% RAIZ4 0.29 — 0.00% PCAR3 2.60 ▲ 0.39% GMAT3 3.88 ▼ 1.02% PSSA3 55.14 ▼ 0.14% CVCB3 1.22 ▼ 9.63% POSI3 3.80 ▼ 2.06% SLCE3 13.53 ▼ 0.59% NATU3 8.55 ▼ 0.12% BRKM5 6.19 ▲ 1.48% RANI3 7.95 ▼ 1.61% CSNA3 5.05 ▼ 0.98% CMIN3 5.33 ▼ 2.20% USIM5 8.23 ▲ 4.18% GGBR4 24.04 ▲ 0.54% ENEV3 25.68 ▼ 1.04% CPFE3 46.87 ▼ 0.68% CMIG4 11.12 ▲ 0.27% EQTL3 39.50 ▼ 0.88% LREN3 13.42 ▼ 1.69% VIVT3 35.52 ▲ 0.14% RAIL3 13.70 ▼ 1.65% KLABIN 17.58 ▲ 1.27% RAIA DROGASIL 18.55 ▲ 0.16% RDOR3 35.78 ▼ 0.25% HAPV3 11.38 ▲ 3.93% FLRY3 16.59 ▲ 1.04% SMTO3 15.45 ▼ 1.72% UGPA3 32.07 ▲ 0.25% VBBR3 34.92 ▲ 1.60% BBSE3 41.12 ▼ 0.15% BPAC11 56.18 ▼ 0.72% CURY3 30.67 ▼ 1.98% AERI3 2.02 — 0.00% VIVARA 22.44 ▼ 3.90% COMPASS 24.88 ▼ 0.12% VAMOS 3.17 ▲ 0.32% SANB11 26.65 ▼ 0.67% ASAI3 8.50 ▼ 0.70% SBSP3 29.22 ▼ 0.27% WALMEX 49.52 ▼ 0.08% GMEXICO 200.05 ▲ 0.41% FEMSA 225.68 ▲ 0.28% CEMEX 22.69 ▼ 0.40% GFNORTE 181.34 ▲ 0.53% BIMBO 58.00 ▲ 0.14% TELEVISA 9.57 ▲ 0.53% AMX 23.00 ▲ 0.97% GAP 386.00 ▼ 1.47% ASUR 279.71 ▼ 0.44% OMA 230.06 ▼ 1.30% KOF 181.10 ▲ 1.20% GRUMA 287.32 ▲ 0.34% KIMBER 38.67 ▼ 0.28% SQM-B 65,450 ▼ 0.91% COPEC 6,250 ▲ 2.02% BSANTANDER 77.00 ▼ 1.48% FALABELLA 5,835 ▼ 0.31% ENELAM 84.04 ▼ 0.90% CENCOSUD 1,995 ▼ 0.50% CMPC 1,070 ▼ 0.37% BANCO CHILE 188.50 ▼ 0.20% LATAM AIR 24.76 ▼ 2.52% YPF 77,900 ▲ 2.40% GGAL 7,860 ▼ 0.06% PAMPA 5,170 ▲ 1.17% TXAR 665.00 ▲ 0.45% ALUAR 949.50 ▲ 1.01% TGS 9,370 ▼ 0.16% CEPU 2,264 ▲ 0.18% MIRGOR 16,875 ▲ 0.75% COME 43.84 ▼ 1.39% LOMA NEGRA 3,535 ▼ 0.63% BYMA 299.00 ▼ 0.83% TELECOM ARG 4,150 ▼ 0.72% ECOPETROL 16.09 ▲ 1.84% BANCOLOMBIA 80.41 ▲ 1.18% GRUPO AVAL 4.92 ▼ 1.01% CREDICORP 390.70 ▲ 0.84% SOUTHERN COPPER 172.48 ▼ 1.81% BUENAVENTURA 30.24 ▲ 0.23% MERCADOLIBRE 1,814 ▼ 2.34% NUBANK 13.59 ▼ 1.45% XP 16.67 ▼ 0.06% PAGSEGURO 9.04 ▼ 1.20% STONE 11.15 ▼ 0.45% GLOBANT 32.23 ▲ 0.09% TECNOGLASS 46.48 ▼ 0.75% GAP AIRPORT 220.91 ▼ 1.94% ASUR 279.71 ▼ 0.44% OMA AIRPORT 105.31 ▼ 1.77% AMX ADR 26.27 ▲ 0.50% FEMSA ADR 129.02 ▼ 0.36% CEMEX ADR 12.98 ▼ 0.92% PETROBRAS ADR 17.97 ▲ 2.86% VALE ADR 14.19 ▼ 0.21% ITAU ADR 8.21 ▼ 1.14% SANTANDER BR 5.24 ▼ 1.04% AMBEV ADR 3.03 ▼ 0.66% CSN 0.99 ▼ 0.89% GERDAU 4.73 ▲ 0.11% LATAM ADR 52.56 ▼ 1.17% BTC 63,911 ▲ 0.02% ETH 1,842 ▲ 0.05% SOL 75.07 ▲ 0.08% XRP 1.09 ▼ 0.02% BNB 566.64 ▼ 0.20% ADA 0.17 ▼ 0.09% DOGE 0.07 — 0.00% AVAX 6.62 ▲ 0.61% LINK 8.25 ▼ 0.04% DOT 0.85 ▲ 0.01% LTC 45.46 ▲ 0.70% BCH 218.81 ▼ 0.42% TRX 0.32 ▼ 0.17% XLM 0.18 ▼ 0.67% HBAR 0.07 ▲ 0.47% NEAR 1.92 ▼ 0.23% ATOM 1.50 ▼ 0.69% AAVE 88.48 ▼ 1.64% SELIC 14.25% EMBRAER 81.75 ▼ 0.02% EMBRAER ADR 64.09 ▼ 0.44% JBS 11.91 ▼ 1.00% JBS BDR 60.20 ▼ 2.11% MBRF3 15.03 ▼ 1.70% MBRFY 2.90 ▼ 1.02% INTER 5.37 ▼ 3.07%
since 2009
Saturday, July 18, 2026

Covid-19: Updated count of reported injuries and deaths after vaccines in EU member states (January 1)

By · January 10, 2022 · 5 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – EudraVigilance, the European database where adverse reactions to vaccines are reported, had collected as of January 1; 36,257 reports of deaths and 3,244,052 reports of injuries (half of them serious) from people who received some of the four experimental injections licensed at this time within the member countries of the European Union.

In the previous report, dated December 4, the number of reported deaths was 32,649, and injuries were 3,003,296.

Read also: Check out our coverage on curated alternative narratives

EudraVigilance was launched by the European Medicines Agency in 2012 to provide public access to reports of suspected side effects. These reports are submitted electronically to EudraVigilance by national medicines regulatory authorities and pharmaceutical companies that hold marketing authorizations (licenses) for drugs.

Through January 1, 2022, its report lists 36,257 reports of deaths and 3,244,052 reports of injuries following injections with any of the four experimental vaccines currently approved in the EU.

MODERNA – COVID-19 mRNA VACCINE (CX-024414)
PFIZER-BioNTech – COVID-19 mRNA VACCINE
ASTRAZENECA – COVID-19 VACCINE (CHADOX1 NCOV-19)
JANSSEN – COVID-19 VACCINE (AD26.COV2.S )

Of the total number of registered injuries, almost half (1.540.852) are severe injuries*.

*According to Eudravigilance, “seriousness provides information on the suspected undesirable effect; it can be classified as ‘serious’ if it corresponds to a medical event that results in death, is life-threatening, requires hospitalization, results in another medically important condition, or prolongs existing hospitalization, results in persistent or significant disability or incapacity, or is a congenital anomaly/congenital disability.”

RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →

As we have discussed in previous reports, we have the following information thanks to a subscriber to the Health Impact News website in Europe, who is undertaking the work of expanding on the details in the reports of each of the four COVID-19 injections that we include here.

This subscriber volunteered to do this, and it is a lot of work to tabulate each reaction with injuries and deaths, as there is no place in the EudraVigilance system to tabulate all the results.

It should be noted that, just as not all reported deaths and injuries need necessarily be vaccine-related, it is well known that these reports represent a very minimal amount of the actual cases, as most death and injury events are not being reported.

We want to recommend once again reading the analysis ( (in French, please use online translator) made by Laurent Mucchielli, research director of the French National Center for Scientific Research (CNRS), who reviewed several databases of adverse event reports to COVID vaccines worldwide and ended up launching an alert directly to all: “We are facing an unprecedented mortality, and a moratorium must be put on this vaccination”.

Here are the EudraVigilance data summarized up to November 20, 2021.

Total reactions for the Pfizer/BioNTech vaccine:
16,471 deaths and 1,546,829 injuries.
a 01/01/2021

  • 42,225 Blood and lymphatic system disorders, incl. 230 deaths
  • 50,455 Cardiac disorders incl. 2,379 deaths
  • 467 Congenital, familial and genetic disorders, incl. 45 deaths
  • 20,812 Disorders of the ear and labyrinth, incl. 11 deaths
  • 1,616 Endocrine disorders incl. 5 deaths
  • 23,826 Eye disorders incl. 37 deaths
  • 124,211 Gastrointestinal disorders incl. 652 deaths
  • 386,451 General disorders and disorders at site of administration, incl. 4,668 deaths
  • 1,780 Hepatobiliary disorders incl . 83 deaths
  • 17,061 Immune system disorders incl. 86 deaths
  • 67,000 Infections and infestations incl. 1,769 deaths
  • 28,457 Injuries, poisonings and procedural complications, incl. 302 deaths
  • 38,560 Investigations incl. 487 deaths
  • 10496 Disorders of metabolism and nutrition incl. 269 deaths
  • 185,798 Musculoskeletal and Connective Tissue Disorders incl. 204 deaths
  • 1,451 Benign, malignant, malignant and unspecified neoplasms (including cysts and polyps) incl. 136 deaths
  • 255,661 Nervous system disorders incl. 1,756 deaths
  • 2,254 Pregnancy, puerperium and perinatal conditions, incl. 58 deaths
  • 232 Product issues incl. 3 deaths
  • 28,114 Psychiatric disorders incl. 193 deaths
  • 5,594 Renal and urinary disorders incl. 258 deaths
  • 59,397 Reproductive system and breast disorders incl. 6 deaths
  • 66,518 Respiratory, thoracic, and mediastinal disorders incl. 1,801 deaths
  • 71,771 Disorders of skin and subcutaneous tissue, incl. 136 deaths
  • 3,457 Social circumstances incl. 22 deaths
  • 13,685 Medical and surgical procedures incl. 157 deaths
  • 39,480 Vascular disorders incl. 718 deaths

Total reactions to the Moderna vaccine:
10,170 deaths and 465,080 injuries
a 01/01/2021

  • 9,961 Blood and lymphatic system disorders, incl. 113 deaths
  • 15,564 Cardiac disorders, incl. 1,039 deaths
  • 179 Congenital, familial and genetic disorders, incl. 9 deaths
  • 5,591 Hearing and labyrinth disorders, incl. 6 deaths
  • 443 Endocrine disorders, incl. 6 deaths
  • 6,731 Eye disorders incl. 36 deaths
  • 38,098 Gastrointestinal disorders incl. 380 deaths
  • 123,337 General disorders and disorders at site of administration, incl. 3,392 deaths
  • 731 Hepatobiliary disorders incl. 51 deaths
  • 4,671 Immunological system disorders, incl. 19 deaths
  • 18,236 Infections and infestations, incl. 965 deaths
  • 9,241 Injuries, intoxications and procedural complications, incl. 191 deaths
  • 10,065 Investigations incl. 321 deaths
  • 4,394 Disorders of metabolism and nutrition incl. 247 deaths
  • 56,097 Musculoskeletal and connective tissue disorders incl. 208 deaths
  • 628 Benign, malignant, malignant and unspecified neoplasms (including cysts and polyps) incl. 79 deaths
  • 78,044 Disorders of the nervous system, incl. 965 deaths
  • 815 Pregnancy, puerperium and perinatal conditions, incl. 6 deaths
  • 92 Product issues incl. 4 deaths
  • 8,416 Psychiatric disorders, incl. 169 deaths
  • 2,725 Renal and urinary disorders incl. 197 deaths
  • 10,682 Reproductive system and breast disorders, incl. 9 deaths
  • 20,529 Respiratory, thoracic, and mediastinal disorders incl. 1,077 deaths
  • 24,552 Disorders of the skin and subcutaneous tissue, incl. 90 deaths
  • 2,029 Social circumstances incl. 41 deaths
  • 2,227 Medical and surgical procedures, incl. 172 deaths
  • 11,002 Vascular disorders incl. 378 deaths

Total reactions for the Oxford/AstraZeneca vaccine:
7,371 deaths and 1,117,914 injuries.
a 01/01/2021

  • 13,616 Blood and lymphatic system disorders incl. 261 deaths
  • 20,296 Cardiac disorders incl. 788 deaths
  • 215 Familial congenital and genetic disorders, incl. 6 deaths
  • 13157 Disorders of the ear and labyrinth, incl. 6 deaths
  • 664 Endocrine disorders incl. 5 deaths
  • 19,618 Ocular disorders incl. 30 deaths
  • 105,367 Gastrointestinal disorders incl. 393 deaths
  • 293,748 General disorders and administration site disorders incl. 1,740 deaths
  • 1,004 Hepatobiliary disorders incl. 66 deaths
  • 5,228 Disorders of the immune system, incl. 35 deaths
  • 36,265 Infections and infestations incl. 564 deaths
  • 13,023 Poisoning due to injuries and procedural complications, incl. 188 deaths
  • 24,589 Investigations incl. 191 deaths
  • 12,747 Disorders of metabolism and nutrition incl. 113 deaths
  • 164,732 Musculoskeletal and connective tissue disorders incl. 144 deaths
  • 704 Benign malignant and unspecified neoplasms (incl. cysts and polyps) incl. 34 deaths
  • 228,601 Nervous system disorders, incl. 1,095 deaths
  • 586 Pregnancy, puerperium and perinatal conditions, incl. 19 deaths
  • 194 Product issues, incl. 1 death
  • 20,622 Psychiatric disorders incl. 65 deaths
  • 4,226 Renal and urinary disorders incl. 71 deaths
  • 16,282 Reproductive system and breast disorders incl. 3 deaths
  • 40,154 Respiratory, thoracic and mediastinal disorders, incl. 963 deaths
  • 50,986 Disorders of the skin and subcutaneous tissue, incl. 59 deaths
  • 1,581 Social circumstances incl. 6 deaths
  • 1,686 Medical and surgical procedures incl. 28 deaths
  • 28,023 Vascular disorders incl. 497 deaths

Total reactions for Johnson & Johnson vaccine:
2,245 deaths and 114,229 injuries.
a 01/01/2021

  • 1,113 Blood and lymphatic system disorders, incl. 46 deaths
  • 2,196 Cardiac disorders, incl. 186 deaths
  • 40 Congenital, familial, and genetic disorders, incl. 1 death
  • 1,227 Disorders of the ear and labyrinth, incl. 3 deaths
  • 93 Endocrine disorders incl. 1 death
  • 1,548 Ocular disorders incl. 9 deaths
  • 9,141 Gastrointestinal disorders incl. 87 deaths
  • 30,336 General disorders and administration site disorders, incl. 623 deaths
  • 143 Hepatobiliary disorders incl. 13 deaths
  • 509 Immune system disorders incl. 10 deaths
  • 5,832 Infections and infestations incl. 187 deaths
  • 1,060 Injuries, intoxications and procedural complications, incl. 23 deaths
  • 5,197 Investigations incl. 126 deaths
  • 709 Disorders of metabolism and nutrition, incl. 55 death
  • 16,069 Disorders of musculoskeletal and connective tissue, incl. 50 deaths
  • 80 Benign, malignant and unspecified neoplasms (incl. cysts and polyps) incl. 8 deaths
  • 21,863 Nervous system disorders, incl. 234 deaths
  • 52 Pregnancy, puerperium and perinatal conditions incl. 1 death
  • 29 Product problems
  • 1,627 Psychiatric disorders, incl. 21 deaths
  • 485 Renal and urinary disorders incl. 29 deaths
  • 2,625 Reproductive system and breast disorders, incl. 6 deaths
  • 4,115 Respiratory, thoracic and mediastinal disorders incl. 283 deaths
  • 3,506 Disorders of the skin and subcutaneous tissue, incl. 10 deaths
  • 372 Social circumstances incl. 4 deaths
  • 785 Medical and surgical procedures incl. 69 deaths
  • 3,477 Vascular disorders incl. 160 deaths

This is public information funded by the European Medicines Agency (EMA), and anyone can use the EudraVigilance system and verify this data.

Join us on Telegram: t.me/theriotimes

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.